Skip to content

Application of health guidance based on dietary pattern in patients with early gastric cancer after ESD operation

Application of health guidance based on dietary pattern in patients with early gastric cancer after ESD operation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045405
Enrollment
Unknown
Registered
2021-04-14
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

The diet improvement group and the diet unimprovement group:Dietary guidelines

Sponsors

Affiliated Hospital of Binzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 75 years old (including 18 and 75 years old); 2. Early gastric cancer was diagnosed by endoscopy, and the surrounding mucosa background was gastric mucosa atrophy; 3. The lesions were completely resected by ESD, and the pathological manifestations were high-grade intraepithelial neoplasia or highly or moderately differentiated adenocarcinoma. No residual horizontal margin, infiltration depth of vertical margin <= 500µm, no vascular or vascular metastasis, and no distant metastasis; 4. Current treatment: eradication of Helicobacter pylori with quadruple therapy and easy digestion, non-stimulation and low-salt diet; 5. Patients are able and willing to comply with the requirements of the protocol, have the ability to read and write, and can understand and fill in the patient diary.

Exclusion criteria

Exclusion criteria: 1. Complicated with diabetes, cardiovascular and cerebrovascular diseases, liver (such as liver cancer, hepatitis B, etc.), hematopoietic diseases, etc.; 2. Accompanied by mental illness can not cooperate; 3. Those who do not meet the inclusion criteria, cannot judge the efficacy or have incomplete data that affect the efficacy or safety.

Design outcomes

Secondary

MeasureTime frame
hemoglobin;

Countries

China

Contacts

Public ContactGao Tao

Affiliated Hospital of Binzhou Medical College

gaotao1997@163.com+86 13954398575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026